Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 2Not yet recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Breast 2

Conditions

Neoplasms 3Pancreatic Neoplasms 2Carcinoma, Hepatocellular 2Breast Neoplasms 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Thyroid Nodule 1Prostatic Neoplasms 1Pancreatic Cyst 1Liver Neoplasms 1Glioblastoma 1Disease 1Depression 1Colorectal Neoplasms 1Camurati-Engelmann Syndrome 1Breast Cancer Female 1Brain Neoplasms 1Astrocytoma 1Anxiety Disorders 1

Interventions

Trastuzumab 350Paclitaxel 334Cyclophosphamide 315Docetaxel 291Capecitabine 181Doxorubicin 180Letrozole 166Tamoxifen 145Bevacizumab 124Fulvestrant 118Carboplatin 118exemestane 111Lapatinib 111Anastrozole 111Radiotherapy 105Epirubicin 104Gemcitabine 97palbociclib 84Exercise 78Vinorelbine 77Fluorouracil 77Surveys and Questionnaires 71pertuzumab 67Filgrastim 64Albumin-Bound Paclitaxel 64eribulin 55Magnetic Resonance Spectroscopy 55Everolimus 52Blood Specimen Collection 51Zoledronic Acid 50

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Breast Neoplasms × Drug Delivery Systems × Clear all
NCT02690805 2021-04-19

Predicting Neoadjuvant Chemotherapy Response by Using a Combined MRI and Scinti-Mammography (MRI-SMM) System

University of California, Irvine

Completed
16 enrolled
Breast

Breast Neoplasms

NCT01373671 2020-08-07

DBT

Siemens Medical Solutions USA - CSG

Phase NA Completed
764 enrolled 5 charts
Breast

Breast Neoplasms, Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡